Ingevity (NGVT)
(Delayed Data from NYSE)
$48.51 USD
+0.64 (1.34%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $48.49 -0.02 (-0.04%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
NGVT 48.51 +0.64(1.34%)
Will NGVT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NGVT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NGVT
Analysts Estimate AdvanSix (ASIX) to Report a Decline in Earnings: What to Look Out for
LyondellBasell (LYB) to Post Q1 Earnings: What's in Store?
NGVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ingevity (NGVT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Ingevity (NGVT) Up 0.8% Since Last Earnings Report: Can It Continue?
Ingevity's (NGVT) Earnings and Sales Surpass Estimates in Q4
Other News for NGVT
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Stocks Muted As Oil Prices Take A Breather
Ingevity rises 7.8%
What's Driving Ingevity Corp's Surprising 11% Stock Rally?
NGVT Crosses Above Key Moving Average Level